2018
DOI: 10.18332/tid/84277
|View full text |Cite
|
Sign up to set email alerts
|

Could be applied genetic markers to smoking cessation treatment?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A recent study highlights the contribution of CHRNA4 (rs1044396 C> T) polymorphism in the choice of the best drug for anti-smoking treatment. According to this study, the effectiveness of varenicline is higher for patients with a CT or TT genotype than for those with CC 36 .…”
Section: Chrn Gene Polymorphismsmentioning
confidence: 65%
“…A recent study highlights the contribution of CHRNA4 (rs1044396 C> T) polymorphism in the choice of the best drug for anti-smoking treatment. According to this study, the effectiveness of varenicline is higher for patients with a CT or TT genotype than for those with CC 36 .…”
Section: Chrn Gene Polymorphismsmentioning
confidence: 65%